Nicole M. Ramocki, Ph.D.

Kay Lund	grad student	2008	UNC Chapel Hill
(IRS-1 and SOCS2 are key regulators of insulin-like growth factor signaling in intestinal cancer.)

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.
Newton VA, Ramocki NM, Scull BP, et al. (2010) Suppressor of cytokine signaling-2 gene disruption promotes Apc(Min/+) tumorigenesis and activator protein-1 activation. The American Journal of Pathology. 176: 2320-32
Ramocki NM, Wilkins HR, Magness ST, et al. (2008) Insulin receptor substrate-1 deficiency promotes apoptosis in the putative intestinal crypt stem cell region, limits Apcmin/+ tumors, and regulates Sox9. Endocrinology. 149: 261-7
Michaylira CZ, Simmons JG, Ramocki NM, et al. (2006) Suppressor of cytokine signaling-2 limits intestinal growth and enterotrophic actions of IGF-I in vivo. American Journal of Physiology. Gastrointestinal and Liver Physiology. 291: G472-81
Michaylira CZ, Ramocki NM, Simmons JG, et al. (2006) Haplotype insufficiency for suppressor of cytokine signaling-2 enhances intestinal growth and promotes polyp formation in growth hormone-transgenic mice. Endocrinology. 147: 1632-41
Ramocki N, Keku T, Ney D, et al. (2005) Diet, Insulin-like Growth Factors and Intestinal Growth, Proliferation, Apoptosis, and Cancer Annual Review of Nutrition. 60407070428018